Ben Portney is an investing partner on Andreessen Horowitz's Bio + Health team focused on early-stage companies building platforms for therapeutic discovery and development.
Ben Portney is an investing partner on Andreessen Horowitz's Bio + Health team focused on early-stage companies building platforms for therapeutic discovery and development.
Career
Ben Portney holds a PhD, Biochemistry and Molecular Biology from University of Maryland, Baltimore and a BS, Biology from University of Maryland, College Park.
Investing Partner, Bio + Health at Andreessen Horowitz (a16z) from 2022-03 to PresentInvests in early-stage platforms for therapeutic discovery and development.
VentureLabs Fellow, Associate and Senior Associate at Flagship Pioneering from 2018-06 to 2022-03Worked on a venture-creation team to found and grow biotechnology companies.
Equity Research Extern at T. Rowe Price from 2018-01 to 2018-04ACResearch Analyst at Actinium Capital from 2016-06 to 2018-04